Lecture 14 - antipsychotics for schizophrenia Flashcards

1
Q

what are the amine transmitters in CNS?

A
  1. noradrenaline
  2. dopamine
  3. serotonin
  4. acetylcholine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how is noradrenaline inactivated?

A

by neuronal re-uptake or metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what metabolises noradrenaline?

A
  1. monoamine oxidase (MAO)
  2. aldehyde reductase
  3. catechol-o-methyl-transferase (COMT)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

function of alpha1 (Gq) noradrenergic receptors

A

widely distributed and involved in motor control, cognition and fear.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

function of alpha2 (Gi) noradrenergic receptors?

A

involved with regulation of blood pressure, sedation and analgesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

function of beta 1 (Gs) noradrenergic receptors?

A

in cortex, striatum and hippocampus contribute to long term effects of antidepressants.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

how is noradrenaline released?

A

‘diffusely’ rather than specific synapses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

characteristics for dopamine

A

involved in several common disorders including schizophrenia and its distribution is more restricted than noradrenaline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

where is dopamine highest in?

A

striatum forming parts of extrapyramidal motor system which is involved in coordination of movement.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

functional aspects of nigrostriatal pathway for dopamine

A

has cell bodies on substantia nigra for fine motor control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

functional aspects of mesocortical and mesolimbic pathway for dopamine

A

pathway distribution leads to stereotypical behaviour. also involved in pleasure and reward related to motivation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

functional aspect of tuberohypophyseal pathway for dopamine

A

has cell bodies in hypothalamus and involved in secretion of some hormones like prolactin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

how is dopamine terminated?

A

by enzymes COMT and MAO which are found both extracellularly and intracellularly and by action of re-uptake transporters.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is rate limiting enzymes for dopamine?

A

tyrosine hydroxylase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

structures for dopamine and noradrenaline?

A

they have similar structures so receptors structure that it binds to is also similar. makes it difficult when finding highly selective drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what metabolite products are measured in a blood sample?

A

DOPAC and HVA

17
Q

function of D1,D5 dopamine receptors

A
  • Gs coupled receptors so stimulate adenylyl cyclase to increase production of cAMP, PKA.
  • D1 has decreased activity in mesocortical contributing to -ve symptoms
18
Q

functions of D2,D3 and D4 receptors

A
  • Gi coupled receptors so inhibit adenylyl cyclase. activates K+ channels and inhibits Ca2+ channels through GABAa receptors.
  • opposes effects of D1 receptor activation
19
Q

D2 action

A

increases activity in mesolimbic system causing +ve symptoms and is found in pituitary. more pharmacologically important.

20
Q

amphetamine action

A

accumulates in vesicles, noradrenaline increases in cytosol so transporters work in revere by releasing noradrenaline to increase signalling and activation of receptors.

21
Q

cocaine action

A

inhibits transporter so neurotransmitter is not effectively taken back up so signalling activation is for longer

22
Q

what are the positive symptoms for schizophrenia?

A
  • hallucinations, delusions, thought disorders, defects in selective attention
  • most prevalent in the young
  • D2 receptors implicated
23
Q

what are the negative symptoms for schizophrenia?

A
  • blunting of emotions, withdrawal from social contacts, flattening of emotional responses, anhedonia
  • prevalent in elderly and prognosis is worse
  • D1 receptors implicated
24
Q

genetic causes of schizophrenia

A

found to have hereditary origin as a result of abnormalities which arise early in life and disrupt normal development of the brain

25
environmental causes of schizophrenia
- consumption of cannabis and drugs that increase dopamine signalling. - ketamine gives rise to +ve symptoms - LSD produces hallucinations and other schizophrenia like symptoms
26
how does mesolimbic pathway cause +ve symptoms?
in mesolimbic areas, NMDA hypofunction results in increased dopamine signalling because NMDA receptors are on inhibitory GABAergic interneurons
27
how does mesocortical pathway cause -ve symptoms?
with cognitive impairment, NMDA receptor hypofunction reduced activity of dopaminergic neurons, causing -ve symptoms
28
what does dopamine receptors in chemoreceptor zone cause?
nausea and vomiting where the zones lies outside the BBB, co-administration with D2 antagonists that cannot cross BBB used to alleviate side effects
29
first generation antipsychotics (typical)
e.g. chlorpromazine and haloperidol - have unwanted side effects including motor disturbances (extrapyramidal effects) and prolactin secretion. - treat severe anxiety and violent patients
30
second generation antipsychotics (atypical)
e.g. clozapine, risperidone - some have enhanced selectivity for D2 receptors and less extrapyramidal side effects. - more effective against -ve symptoms as well as +ve symptoms
31
action of clozapine
has D1 and D2 selectivity but more antimuscarinic to reduce extrapyramidal effects as muscarinic receptor activation contributes to extrapyramidal effects.
32
unwanted effects of antipsychotic drugs
- worst symptom is dyskinesia where there is uncontrolled muscle movements. - increased prolactin release - sedation, hypotension and weight gain - dry mouth and blurred vision